Clinical Trial Update: Efficacy of Riluzole in Surgical Treatment for Cervical Spondylotic Myelopathy (CSM-Protect) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial assessing riluzole for surgical treatment of cervical spondylotic myelopathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Spondylotic Myelopathy

Drugs mentioned

• Riluzole (riluzole)

Snippet

Sponsor: AOSpine North America Research Network | Conditions: Cervical Spondylotic Myelopathy | Phase 3 | Status: COMPLETED